Kailera Therapeutics IPO Review
Kailera Therapeutics IPO Pages
📝
Detailed review coming soon
Our editorial team is preparing an in-depth analysis of Kailera Therapeutics IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.
Price / Issue Price
$16
Issue Size
$625 M
Type
Mainboard
Exchange
Nasdaq
Sector
Healthcare & Pharma
Already listed.
Issued at $16, listed at $26
(+62.50%)
on 17 Apr 2026.
About Kailera Therapeutics
Kailera Therapeutics is a biopharmaceutical company developing oral and injectable therapies targeting obesity, cardiometabolic disease and related chronic conditions. The company has multiple clinical-stage assets in its pipeline.
IPO Details
- Type
- Mainboard
- Country
- United States
- Sector
- Healthcare & Pharma
- Registrar
- KFin Technologies